Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$462,561,050
+$98,244,752 QoQ
Shares Held
4,080,461
+5.4% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. INCY ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
This page
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $462,561,050 | 4,080,461 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $364,316,298 | 3,870,764 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $343,105,340 | 3,473,781 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $260,211,489 | 3,068,170 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $231,609,320 | 3,401,018 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $191,867,806 | 3,168,750 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $210,539,651 | 3,048,207 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $236,283,566 | 3,574,638 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $216,386,538 | 3,569,557 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $160,558,259 | 2,818,295 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $171,813,652 | 2,736,322 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $226,576,534 | 3,922,045 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $236,625,129 | 3,801,207 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $293,681,715 | 4,063,674 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $219,876,636 | 2,737,508 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $157,309,110 | 2,360,581 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $164,962,619 | 2,171,418 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $141,377,523 | 1,780,125 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $130,417,409 | 1,776,804 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $124,144,935 | 1,804,957 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $114,475,012 | 1,360,692 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $100,316,350 | 1,234,359 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $90,118,842 | 1,036,087 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $238,753,622 | 2,660,504 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $273,332,135 | 2,628,952 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $242,414,214 | 3,310,313 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||